The U.S. Food and Drug Administration (FDA) approval of ibrutinib (Imbruvica ®) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood ...
The Golden Bachelor’s Gerry Turner is opening up about a recent medical diagnosis. He told People that he was diagnosed with a slow-growing blood marrow cancer in early 2024. The news comes eight ...
Gerry Turner rose to prominence as a septuagenarian star of a reality dating show. In an interview with People, he said he has a type of non-Hodgkin lymphoma. By Callie Holtermann Gerry Turner, the ...
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble. Patients with Waldenstrom macroglobulinemia (WM) should ...
Rare diseases affect fewer than 1 in 2,000 people individually. However, with over 7,000 different types identified, their global impact is significant. In the Asia-Pacific region, approximately 258 ...
Rare diseases affect fewer than 1 in 2,000 people individually. However, with over 7,000 different types identified, their global impact is significant. In the Asia-Pacific region, approximately 258 ...
Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities Very good partial response (VGPR) rates increased over time and were ...
Nurix Therapeutics has won a key U.S. Food and Drug Administration designation for its lead asset bexobrutideg in a rare type of non-Hodgkin's lymphoma. Nurix on Monday said the FDA granted ...
US biotech ImmunityBio has reported two ongoing complete remissions lasting seven and 15 months in patients with Waldenstrom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results